Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FEFHW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,157
Award facts
- Contract value 100% obligated
- $83,156.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 60-count tablets of Xifaxan 550 mg, with a ceiling value of $83,156.54 under a firm fixed-price contract. The order has an ultimate completion date of July 25, 2025, and represents a non-competitive delivery order issuance. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 vehicle running through December 2026 that enables comprehensive global pharmaceutical support to military healthcare programs worldwide.
The delivery order falls within AmerisourceBergen Drug Corp's extensive portfolio of pharmaceutical product deliveries to the Defense Logistics Agency's Medical Supply Chain. As a critical vendor for federal medical procurement, the company maintains the capability to fulfill competitive procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. The firm fixed-price contract type ensures cost predictability, while the non-set-aside designation indicates this award was issued through open competition, reflecting the contractor's demonstrated capability to meet federal procurement standards for pharmaceutical distribution and supply chain management.
Quick answers
Who was awarded contract SPE2DB25FEFHW?
SPE2DB25FEFHW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FEFHW worth?
The government has obligated $83,157 on SPE2DB25FEFHW.
Is contract SPE2DB25FEFHW an order under another contract?
Yes. SPE2DB25FEFHW is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEFHW competed?
The extent of competition for SPE2DB25FEFHW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award